NUsurface Meniscus Implant
Damaged or deteriorating meniscus tissue
Investigational (Implied Phase 3/Pivotal)Active
Key Facts
Indication
Damaged or deteriorating meniscus tissue
Phase
Investigational (Implied Phase 3/Pivotal)
Status
Active
Company
About NUsurface
NUsurface is a private medical device company developing the first 'artificial meniscus' implant, a novel orthopedic device intended to treat patients with damaged meniscus tissue. The company's technology is currently in the investigational stage in the United States, limited to clinical studies and not yet commercially available. Its strategic goal is to offer a modern alternative to traditional knee surgery, potentially delaying or avoiding the need for total knee replacement. The company is focused on clinical validation to support future regulatory approval and market entry.
View full company profile